Researcher
Anouk Vervaeck
- Disciplines:Other engineering and technology not elsewhere classified, Engineering instrumentation, Nuclear engineering, Risk engineering, Product safety, Process safety, Other natural sciences not elsewhere classified, Safety engineering not elsewhere classified
Affiliations
- Department of Pharmaceutics (Department)
Member
From10 Aug 2010 → 20 Sep 2015
Publications
1 - 8 of 8
- In-vivo evaluation of apocynin for prevention of Helicobacter pylori-induced gastric carcinogenesis(2017)
Authors: Tessa Horemans, Gaëlle Boulet, Marian van Kerckhoven, Johannes Bogers, Sofie Thys, Chris Vervaet, Anouk Vervaeck, Peter Delputte, Louis Maes, Paul Cos
Pages: 10 - 16 - Pharmacokinetic analysis of modified-release metoprolol formulations : an interspecies comparison(2017)
Authors: Elien De Thaye, Anouk Vervaeck, Eleonora Marostica, Chris Vervaet, An Vermeulen
Pages: 135 - 142 - Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding(2015)
Authors: Bart Claeys, Anouk Vervaeck, Xander Hillewaere, Sam Possemiers, Laurent Hansen, Thomas De Beer, Chris Vervaet
Pages: 44 - 52 - Fatty acids for controlled release applications: a comparison between prilling and solid lipid extrusion as manufacturing techniques(2015)
Authors: Anouk Vervaeck, Tinne Monteyne, Florence Siepmann, Matthieu Boone, Thomas De Beer, Jürgen Siepmann, Chris Vervaet
Pages: 173 - 184 - Prilling of fatty acids as innovative technology for oral controlled release multiple-unit systems(2015)
Authors: Anouk Vervaeck
- Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations(2014)
Authors: Anouk Vervaeck, Tinne Monteyne, Lien Saerens, Thomas De Beer, Chris Vervaet
Pages: 472 - 482 - Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms(2013)
Authors: Anouk Vervaeck, Lien Saerens, Bruno De Geest, Thomas De Beer, R Carleer, P Adriaensens, Chris Vervaet
Pages: 587 - 596 - Poly(2-ethyl-2-oxazoline) as matrix excipient for drug formulation by hot melt extrusion and injection molding(2012)
Authors: Bart Claeys, Anouk Vervaeck, Chris Vervaet, Richard Hoogenboom, Bruno De Geest
Pages: 1701 - 1707